Prudential Financial’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$151K Buy
+32,440
New +$147K ﹤0.01% 2359
2023
Q4
– Sell
-11,200
Closed -$29.2K – 2692
2023
Q3
$29.2K Hold
11,200
– – ﹤0.01% 2550
2023
Q2
$40.1K Buy
+11,200
New +$35.9K ﹤0.01% 2556

Other funds holding ORMP

Prudential Financial's ORMP Position: Q3 2026 in Review

Prudential Financial opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 32,440 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #2359 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ORMP as recently as Q3 2023.

Prudential Financial first reported a position in ORMP in Q2 2023 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.

  • Prudential Financial held 32,440 shares of Oramed Pharmaceuticals worth $151K as of Q3 2026.
  • Oramed Pharmaceuticals was a new Prudential Financial position in Q3 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2359 holding.
  • Prudential Financial first reported a position in Oramed Pharmaceuticals in Q2 2023 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.